These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9532859)

  • 1. HA coating. Ten-year experience with the CORAIL system in primary THA. The Artro Group.
    Vidalain JP
    Acta Orthop Belg; 1997; 63 Suppl 1():93-5. PubMed ID: 9532859
    [No Abstract]   [Full Text] [Related]  

  • 2. Eight years results of HA-coated primary total hip replacement.
    Geesink R; Hoefnagels N
    Acta Orthop Belg; 1997; 63 Suppl 1():72-5. PubMed ID: 9532856
    [No Abstract]   [Full Text] [Related]  

  • 3. Revision total hip arthroplasty using hydroxylapatite-coated implants.
    Geesink R; Hoefnagels N
    Acta Orthop Belg; 1997; 63 Suppl 1():77-80. PubMed ID: 9532857
    [No Abstract]   [Full Text] [Related]  

  • 4. The Furlong hydroxyapatite-coated total hip replacement in patients under age 51. A 6-year follow-up study.
    Loupasis G; Morris EW; Hyde ID
    Acta Orthop Belg; 1998 Mar; 64(1):17-24. PubMed ID: 9586246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double coating TI-HAP: 5 years results with the total hip prosthesis alliance.
    Trillaud JM
    Acta Orthop Belg; 1997; 63 Suppl 1():100-1. PubMed ID: 9532861
    [No Abstract]   [Full Text] [Related]  

  • 6. Excellent results of HA coating on a grit-blasted stem: 245 patients followed for 8-12 years.
    Reikerås O; Gunderson RB
    Acta Orthop Scand; 2003 Apr; 74(2):140-5. PubMed ID: 12807319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HA-coated ABG socket in revision arthroplasty.
    Van Hoye M; De Cuyper A; Naert P; Brabants K
    Acta Orthop Belg; 1997; 63 Suppl 1():103-5. PubMed ID: 9532862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term experience with the combined ARBOND hydroxyapatite coating in implant osteointegration].
    Landor I; Vavrík P; Jahoda D; Pokorný D; Ballay R; Sosna A
    Acta Chir Orthop Traumatol Cech; 2009 Jun; 76(3):172-8. PubMed ID: 19595277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyapatite coated hip prosthesis followed up for 5 years.
    Oosterbos CJ; Rahmy AI; Tonino AJ
    Int Orthop; 2001; 25(1):17-21. PubMed ID: 11374261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Failure of the polyethylene cups directly implanted into bone. A study of 32 Freeman cups after 9 years of followup (6-12 years)].
    Boisgard S; Levai JP; Jaud E; Guyonnet G; Chatenet T
    Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):700-4. PubMed ID: 10192120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection following total hip arthroplasty with a hydroxyapatite-coated prosthesis: histology and histomorphometry 6 years after implantation and infection--a case report.
    Oosterbos CK; Rahmy AI; Tonino AJ; Thèrin M
    Acta Orthop Scand; 2003 Apr; 74(2):216-20. PubMed ID: 12807333
    [No Abstract]   [Full Text] [Related]  

  • 12. Minimum 10-year results of a tapered cementless hip replacement.
    Sakalkale DP; Eng K; Hozack WJ; Rothman RH
    Clin Orthop Relat Res; 1999 May; (362):138-44. PubMed ID: 10335292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with proximal ingrowth implantation in hip revision surgery.
    Cameron H
    Acta Orthop Belg; 1997; 63 Suppl 1():66-8. PubMed ID: 9532855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total hip arthroplasty with the porous-coated anatomic (PCA) prosthesis: the femoral component.
    Van Wellen P; Demuynck M; Haentjens P; De Valkeneer O; Casteleyn PP; Vanden Berghe I; Opdecam P; Kesteleyn P
    Acta Orthop Belg; 1993; 59 Suppl 1():282-6. PubMed ID: 8116410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of a hydroxyapatite-coated primary stem in revision total hip arthroplasty.
    Kelly SJ; Incavo SJ; Beynnon B
    J Arthroplasty; 2006 Jan; 21(1):64-71. PubMed ID: 16446187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of femoral component version change in primary THA using the S-ROM femoral component.
    Kindsfater KA; Politi JR; Dennis DA; Sychterz Terefenko CJ
    Orthopedics; 2011 Apr; 34(4):. PubMed ID: 21469634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results at a minimum of 10 years of follow-up for AMS and PerFix HA-coated cementless total hip arthroplasty: impact of cross-linked polyethylene on implant longevity.
    Nakashima Y; Sato T; Yamamoto T; Motomura G; Ohishi M; Hamai S; Akiyama M; Hirata M; Hara D; Iwamoto Y
    J Orthop Sci; 2013 Nov; 18(6):962-8. PubMed ID: 23963589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What's new in hip arthroplasty.
    Huo MH; Parvizi J; Gilbert NF
    J Bone Joint Surg Am; 2006 Sep; 88(9):2100-13. PubMed ID: 16951129
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone reaction to a biomimetic third-generation hydroxyapatite coating and new surface treatment for the Symax hip stem.
    ten Broeke RH; Alves A; Baumann A; Arts JJ; Geesink RG
    J Bone Joint Surg Br; 2011 Jun; 93(6):760-8. PubMed ID: 21586774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osseointegration of total hip arthroplasties: studies in humans and animals.
    Song Y; Beaupre G; Goodman SB
    J Long Term Eff Med Implants; 1999; 9(1-2):77-112. PubMed ID: 10537590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.